Share Page
Post on LinkedIn
Copy URL to Clipboard
Copied!

cancer markers and prediction of treatment and managments of cancer patients?

Which specific multi-omic configurations of cancer stem cell (CSC) markers—such as OCT4, Nanog, and NOX2—are most reliable for predicting clinical resistance to immune checkpoint inhibitors in solid tumors?"

Post an Answer

Sign In to Answer
1 Answer
Accepted, Highest Scores first Newest first
1
Imtiaz Wani
These cancer cell markers are presently classified as Inclusive markers  and Exclusive markers.Presently , their expression has been  correlated  and further evolving , correlating with   diagnostic , prognostic and long term outcomes in management of solid tomours.A significant analysis of these  markers is also role in assessing treatment resistance.Solid tomours of colon , breast and ovary have prominent study of these  cancer cell biomarkers
Type
Public
Status
Answered
Bounty
1 Ping Credit
Created
09/08/2026
Answer Count
1
Vote Count
1
Creator
Ioannis K. Toliopoulos
Tags
CarcinogenesisImmunologyMolecular BiologyOncologyPharmacology